154 related articles for article (PubMed ID: 8927592)
1. [Molecular pathogenesis of experimental membraneous glomerulonephritis (Heymann nephritis)].
Kerjaschki D
Pathologe; 1996 Jul; 17(4):262-8. PubMed ID: 8927592
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis).
Kerjaschki D; Neale TJ
J Am Soc Nephrol; 1996 Dec; 7(12):2518-26. PubMed ID: 8989729
[TBL] [Abstract][Full Text] [Related]
3. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
Makker SP; Tramontano A
J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
[TBL] [Abstract][Full Text] [Related]
4. All four putative ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis.
Yamazaki H; Ullrich R; Exner M; Saito A; Orlando RA; Kerjaschki D; Farquhar MG
J Am Soc Nephrol; 1998 Sep; 9(9):1638-44. PubMed ID: 9727372
[TBL] [Abstract][Full Text] [Related]
5. Induction of Heymann nephritis with a gp330/megalin fusion protein.
Raychowdhury R; Zheng G; Brown D; McCluskey RT
Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
[TBL] [Abstract][Full Text] [Related]
6. Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein.
Kerjaschki D; Ullrich R; Exner M; Orlando RA; Farquhar MG
J Exp Med; 1996 May; 183(5):2007-15. PubMed ID: 8642311
[TBL] [Abstract][Full Text] [Related]
7. Pathogenetic concepts of membranous glomerulopathy (MGN).
Kerjaschki D
J Nephrol; 2000; 13 Suppl 3():S96-100. PubMed ID: 11132040
[TBL] [Abstract][Full Text] [Related]
8. The Heymann nephritis antigenic complex: megalin (gp330) and RAP.
Farquhar MG; Saito A; Kerjaschki D; Orlando RA
J Am Soc Nephrol; 1995 Jul; 6(1):35-47. PubMed ID: 7579068
[TBL] [Abstract][Full Text] [Related]
9. Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein.
Orlando RA; Kerjaschki D; Farquhar MG
J Am Soc Nephrol; 1995 Jul; 6(1):61-7. PubMed ID: 7579071
[TBL] [Abstract][Full Text] [Related]
10. gp330 and RAP: the Heymann nephritis antigenic complex.
Farquhar MG; Kerjaschki D; Lundstrom M; Orlando RA
Ann N Y Acad Sci; 1994 Sep; 737():96-113. PubMed ID: 7944157
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of membranous glomerulonephritis: from morphology to molecules.
Kerjaschki D
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 58(4):253-71. PubMed ID: 1970689
[No Abstract] [Full Text] [Related]
12. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
Susani M; Schulze M; Exner M; Kerjaschki D
Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
[TBL] [Abstract][Full Text] [Related]
13. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
Kerjaschki D
Verh Dtsch Ges Pathol; 1989; 73():24-35. PubMed ID: 2482609
[TBL] [Abstract][Full Text] [Related]
14. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
[TBL] [Abstract][Full Text] [Related]
15. A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease.
Oleinikov AV; Feliz BJ; Makker SP
J Am Soc Nephrol; 2000 Jan; 11(1):57-64. PubMed ID: 10616840
[TBL] [Abstract][Full Text] [Related]
16. [Immunopathogenesis of glomerulonephritis--new data on the clinical and experimental studies].
Krzymański M
Przegl Lek; 1992; 49(1-2):10-2. PubMed ID: 1454997
[No Abstract] [Full Text] [Related]
17. Membranous nephropathy. Insights from Heymann nephritis.
Cavallo T
Am J Pathol; 1994 Apr; 144(4):651-8. PubMed ID: 8160766
[No Abstract] [Full Text] [Related]
18. Detection of two forms of GP330. Their role in Heymann nephritis.
Bachinsky DR; Zheng G; Niles JL; McLaughlin M; Abbate M; Andres G; Brown D; McCluskey RT
Am J Pathol; 1993 Aug; 143(2):598-611. PubMed ID: 8342605
[TBL] [Abstract][Full Text] [Related]
19. Molecular aspects of immune deposit formation in Heymann nephritis.
Kerjaschki D
Nephrol Dial Transplant; 1992; 7 Suppl 1():16-20. PubMed ID: 1283449
[No Abstract] [Full Text] [Related]
20. Monoclonal antibodies to glomerular antigens.
Ronco P; Sahali D; Cittanova ML; van Leer EH; Chatelet F; Verroust P
Nephrol Dial Transplant; 1992; 7 Suppl 1():9-15. PubMed ID: 1362802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
